NCT01165931View on ClinicalTrials.gov

Coronary Vasomotor Response After Riociguat Exposure

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Coronary Artery Disease

Interventions

DRUG

Riociguat (BAY63-2521)

0.1 mg intracoronary infusion through coronary guide catheter. Single dose. Sequential application after initial vasoactive bolus of Adenosine (non-study drug) and Nitroglycerin (non-study drug).

Trial Locations (1)

02114

Boston